Oncology Practice Management seeks to offer process solutions for all members of the cancer care team—medical, surgical, and radiation oncologists, as well as executives, administrators, and coders/billers.
Physicians have one of the highest suicide rates of any profession. he highest suicide rates of any profession. According to the American Foundation for Suicide Prevention, an estimated 300 physicians die by suicide each year across the United States—nearly 1 per day.
Successful revenue cycle management is a team effort that requires continuous collaboration across multiple departments of an organization. Although all institutions aim for standard industry best practices, the way in which these goals are attained may vary greatly, based on unique workflows, workforces, and needs.
Chicago, IL—The addition of the PD-1 inhibitor pembrolizumab (Keytruda) to chemotherapy with or without bevacizumab (Avastin) resulted in a substantial and clinically meaningful improvement in overall survival in patients with persistent, recurrent, or metastatic cervical cancer, according to the final OS analysis of the phase 3 KEYNOTE-826 trial. The results were presented during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.
Dr Nangia, medical oncologist at Hoag Medical Group in Irvine, CA, discusses key efficacy and safety data from the EMERALD trial, the importance of liquid biopsy testing, and changes in practice brought upon by the approval of ORSERDU (elacestrant).
AstraZeneca, through its Access 360 and AZ&Me programs, offers a range of patient assistance to help streamline access and reimbursement for select AstraZeneca medicines.
Pfizer offers Pfizer Oncology Together, a patient support program to help patients access their prescribed Pfizer Oncology medications, identify financial assistance options, and connect patients to a dedicated Care Champion.
The Guide to Patient Support Services Index can be sorted by Drug or Company to help you quickly access information about programs offered by pharmaceutical companies and novel cancer drugs approved in 2022.